Fragment-Based Drug Discovery (FBDD) with Injection Methodologies [Application Note]
Fragment-based drug design has become an increasingly popular platform for the identification of lead candidates in drug discovery programs.
Over the last decade approaches such as nuclear magnetic resonance (NMR), X-ray crystallography, differential scanning fluorimetry (DSF), and surface plasmon resonance (SPR) have become core technologies in many pharma and biotech settings for the identification of these low-affinity fragment compounds.
This application note describes how the dynamic injection SPR (diSPR) technique, marks a quantum innovation in characterizing molecular interactions.
Over the last decade approaches such as nuclear magnetic resonance (NMR), X-ray crystallography, differential scanning fluorimetry (DSF), and surface plasmon resonance (SPR) have become core technologies in many pharma and biotech settings for the identification of these low-affinity fragment compounds.
This application note describes how the dynamic injection SPR (diSPR) technique, marks a quantum innovation in characterizing molecular interactions.
